Valuation: EMVision Medical Devices Ltd

Market Cap 156M 109M 95.53M 88.31M 81.22M 153M 10.51B 1.06B 414M 5.14B 409M 400M 17.72B P/E 2026 *
-17.1x
P/E 2027 * -14.8x
Enterprise Value 156M 109M 95.53M 88.31M 81.22M 153M 10.51B 1.06B 414M 5.14B 409M 400M 17.72B EV / Sales 2026 *
28.3x
EV / Sales 2027 * 31.1x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day+3.40%
1 week+11.67%
Current month+10.56%
1 month+5.35%
3 months-1.18%
6 months-7.46%
Current year-5.90%
1 week 1.47
Extreme 1.47
1.76
1 month 1.47
Extreme 1.47
1.76
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.18
Extreme 1.175
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
4/23/26 A Buy

Director

10,000 0.0108%
1/2/26 A Expiration

Chairman

300,000 0.3228%
11/18/25 A Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
+3.40%+11.67%-5.63%+39.58% 105M
-0.47%+0.36%+30.99%-1.46% 198B
-0.34%+1.34%+7.86%-17.00% 144B
+1.88%-13.40%-31.69%+1.41% 122B
+0.41%-0.99%-57.40%-17.31% 65.44B
-0.20%-6.67%+11.89%-7.54% 49.36B
+0.65%-0.59%-22.82%-31.15% 44.74B
+0.19%-1.22%+18.18%+6.31% 37.13B
-2.30%-3.26%+28.18%+29.05% 36.23B
-0.64%-0.60%-24.42%-10.03% 28.7B
Average +0.29%-1.73%-4.49%-0.81% 72.62B
Weighted average by Cap. +0.05%-2.62%+0.26%-6.15%

Financials

2026 *2027 *
Net sales 5.5M 3.85M 3.37M 3.12M 2.87M 5.41M 371M 37.3M 14.62M 182M 14.46M 14.14M 626M 5M 3.5M 3.07M 2.84M 2.61M 4.92M 338M 33.91M 13.29M 165M 13.14M 12.86M 569M
Net income -9.1M -6.37M -5.58M -5.16M -4.75M -8.96M -614M -61.71M -24.19M -301M -23.92M -23.4M -1.04B -12M -8.4M -7.36M -6.81M -6.26M -11.81M -810M -81.38M -31.9M -396M -31.54M -30.86M -1.37B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
20/07/26 A$1.675 +3.40% 46,481
17/07/26 A$1.620 -4.42% 30,981
16/07/26 A$1.695 -3.69% 62,245
15/07/26 A$1.760 +15.41% 34,279
14/07/26 A$1.525 +1.33% 75,809
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.675AUD
Average target price
3.150AUD
Spread / Average Target
+88.06%

Annual profits - Rate of surprise